Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2009 Sep 22;23(5):324–330. doi: 10.1002/jcla.20337

Correlation between Etest®, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization

Melyssa Negri 1, Mariana Henriques 1, Terezinha IE Svidzinski 2, Claudete Rodrigues Paula 3, Rosário Oliveira 1,✉
PMCID: PMC6649251  PMID: 19785043

The content is available as a PDF (118.6 KB).

REFERENCES

  • 1. Asmundsdottir LR, Erlendsdottir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. Molecular epidemiology of candidemia: Evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 2008;47:17–24. [DOI] [PubMed] [Google Scholar]
  • 2. Colombo AL, Nucci M, Park BJ, et al. Epidemiology of Candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816–2823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: Results of 28‐month European Confederation of Medical Mycology (ECMM) hospital‐based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317–322. [DOI] [PubMed] [Google Scholar]
  • 4. Nucci M, Colombo AL. Candidemia due to Candida tropicalis: Clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007;58:77–82. [DOI] [PubMed] [Google Scholar]
  • 5. Matsumoto FE, Gandra RF, Ruiz LS, et al. Yeasts isolated from blood and catheter in children from a Public Hospital of São Paulo, Brazil. Mycopathologia 2002;154:63–69. [DOI] [PubMed] [Google Scholar]
  • 6. Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE. Fatores de virulência de Candida spp isoladas de cateteres venosos e mãos de servidores hospitalares. Rev Soc Bras Med Trop 2007;40:91–93. [DOI] [PubMed] [Google Scholar]
  • 7. Ruiz LS, Sugizaki MF, Montelli AC, et al. Fungemia by yeasts in Brazil: Occurrence and phenotypic study of strains isolated at the Public Hospital, Botucatu, São Paulo. J Med Mycol 2005;15:13–21. [Google Scholar]
  • 8. Clinical and Laboratory Standards Institute . Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, M27‐A2, Second ed, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2002.
  • 9. Rex John H, Pfaller Michael A. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002;35:982–989. [DOI] [PubMed] [Google Scholar]
  • 10. Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 2007;59:767–771. [DOI] [PubMed] [Google Scholar]
  • 11. Barry AL, Pfaller MA, Brown SD, et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol 2000;38:3457–3459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Pfaller MA, Boyken L, Messer SA, Hollis RJ, Diekema DJ. Stability of Mueller–Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole. J Clin Microbiol 2004;42:1288–1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Matar MJ, Ostrosky‐Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. Correlation between E‐Test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003;47:1647–1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother 2002;46:1781–1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Silva MRR, Costa MR, Miranda ATB, Fernandes OFL, Costa CR, Paula CR. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients. Rev Inst Med Trop São Paulo 2002;44:121–125. [DOI] [PubMed] [Google Scholar]
  • 16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections In: Olmsted RN, editor. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby, 1996. p A‐1–A‐20. [Google Scholar]
  • 17. Bonassoli LA, Bertoli M, Svidzinski TIE. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect 2005;59:159–162. [DOI] [PubMed] [Google Scholar]
  • 18. Maki DG WC, Sarafin HW. A semiquantitative culture method for identifying intravenous‐catheter‐related infection. N Engl J Med 1977;296:1305–1309. [DOI] [PubMed] [Google Scholar]
  • 19. Kurtzman CP, Fell JW. 1998. The Yeasts, A Taxonomic Study. New York: Elsevier Science Ltd. [Google Scholar]
  • 20. Clinical and Laboratory Standards Institute . Method for antifungal disk diffusion susceptibility testing of yeasts: Approved guideline M44‐A, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2004. [Google Scholar]
  • 21. Pfaller MA, Diekema DJ, Boyken L, Messer SA, Tendolkar S, Hollis RJ. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J Clin Microbiol 2003;41:1875–1880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Traoré O, Springthorpe VS, Sattar SA. A quantitative study of the survival of two species of Candida on porous and non‐porous environmental surfaces and hands. J Appl Microbiol 2002;92:549–555. [DOI] [PubMed] [Google Scholar]
  • 23. Shin JH, Park M‐R, Song JW, et al. Microevolution of Candida albicans strains during catheter‐related candidemia. J Clin Microbiol 2004;42:4025–4031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Tamura NK, Gasparetto A, Svidzinski TIE. Evaluation of the adherence of Candida species to urinary catheters. Mycopathologia 2003;156:269–272. [DOI] [PubMed] [Google Scholar]
  • 25. Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 2000;30:14–18. [DOI] [PubMed] [Google Scholar]
  • 26. Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non‐albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008;46:1206–1213. [DOI] [PubMed] [Google Scholar]
  • 27. Krcmery V, Barnes AJ. Non‐albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002;50:243–260. [DOI] [PubMed] [Google Scholar]
  • 28. Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky‐Zeichner L. Correlation between microdilution, E‐test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol 2006;44:2105–2108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Snydman DR. Shifting patterns in the epidemiology of nosocomial candida infections. Chest 2003;123:500–503. [DOI] [PubMed] [Google Scholar]
  • 30. Arendrup M, Lundgren B, Jensen IM, Hansen BS, Frimodt‐Moller N. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother 2001;47:521–526. [DOI] [PubMed] [Google Scholar]
  • 31. Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: Report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 2003;41:1440–1446. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES